Pharmacelera has been granted with 1M€ by EIC Accelerator

We are happy to announce that our colleagues from Pharmacelera have been granted with 1M€ by EIC Accelerator (ex SME Instrument Phase 2).

Pharmacelera is a deep tech company that wants to revolutionize drug discovery. They are developing PharmScreen, a revolutionary platform based on accurate Quantum-Mechanics (QM) algorithms, Machine Learning (ML) and High-Performance Computing (HPC) to identify molecules with higher chances to become a drug. PharmScreen enables accurate predictions of molecular properties and a holistic search of a larger and richer chemical space, which thereby increases the success rate of lead identification.

Enric Gibert, CEO of Pharmacelera says: “The contribution of John Crockett (partner at Inveniam), Cristina Vilarmau (analyst at Inveniam) and the rest of the team has been very important for this milestone”.

We at Inveniam Group are very happy to have helped Pharmacelera to achieve this great success! We wish you the best luck in all your future projects.

Successful Ventures invests in Devicare

Inveniam has advised Devicare in the round and the closing of a successful transaction with Successful Ventures.
Successful Ventures is a business angels network with more than 100 active investors. In 2019, it has invested 1.8 million euros in 15 technology-based start-ups, and now is starting its journey in the e-health sector with the help of the leading Spanish company in urology, Devicare.

Inveniam presenta: Free Money for Cats

Existen muchas oportunidades de financiación pública no diluida para PYMEs y Start-ups, pero estas son extremadamente competitivas. ¿Sabe cuáles son las más apropiadas para su empresa? ¿Sabe si tiene posibilidades de ganar?

ZeCardio an investment for the heart

ZeClinics Therapeutics is a biopharmaceutical company focused on the development of treatments for cardiovascular diseases. Nowadays cardiovascular diseases are the cause of death of at least a third of the global population. Despite this issue, there is not enough research on this area because all the focus is on fighting cancer.  ZeClinics proposes a revolutionary…

EIC Accelerator call for “green deal” start-ups and SMEs

It has been confirmed that 19 May ’20 will be a one-off EIC Accelerator call for game-changing green innovation and woman-led start-ups and SMEs. All applicants will have to demonstrate their green credentials and explain how their innovation contributes to the goals of The European Green Deal.

Save the Date!

Biocat, the institution that brings together the life sciences and healthcare innovation community in Catalonia and Inveniam Group are pleased to invite you to the first The Investment Readiness Series – Israel Edition, to take place on Sunday May 10 in Tel Aviv The Investment Readiness Series is an initiative of Biocat designed to increase the deal…

Inveniam Group Team at the IQS Tech Fest 2020

Our analyst Cristina Vilarmau, Paolo de Carli and Naia Jiménez have attended the new edition of the IQS Tech Fest. The Festival was the meeting point of industrial entrepreneurship at European level, with the participation of the most disruptive startups of the current ecosystem.

The Inveniam Group team wishes you…

The team at Inveniam Group wishes you peace, joy and prosperity throughout the coming year. Thank you for your continued support and partnership. We look forward to working with you in the years to come.